Related Experiment Video
Updated: Mar 22, 2026

Author Spotlight: A Simple and Cost-Effective Method for Leukocyte Analysis in Semen
Published on: January 19, 2024
Role of Myeloperoxidase in Patients with Chronic Kidney Disease
Bojana Kisic1, Dijana Miric1, Ilija Dragojevic1
1Institute of Biochemistry, Medical Faculty Pristina, Kosovska Mitrovica 38220, Serbia.
Insights
Myeloperoxidase (MPO) contributes to oxidative damage and inflammation in chronic kidney disease (CKD) patients. This enzyme modifies lipoproteins, worsening cardiovascular complications in renal failure.
Area of Science:
- Nephrology
- Biochemistry
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) is a global health issue.
- CKD patients experience oxidative stress and systemic inflammation.
- These conditions lead to severe complications like cardiovascular disease and Type 2 diabetes.
Purpose of the Study:
- To review the role of myeloperoxidase (MPO) in CKD.
- To examine MPO's contribution to oxidative damage in CKD patients.
- To discuss MPO's impact on cardiovascular complications in renal failure.
Main Methods:
- Literature review focusing on MPO's function in CKD.
- Analysis of MPO's role in producing reactive intermediates.
- Examination of MPO-modified lipoproteins and endothelial changes.
Main Results:
- MPO generates reactive/chlorinating intermediates.
- These intermediates cause oxidative damage to biomolecules in CKD patients.
- MPO-induced lipoprotein modification contributes to cardiovascular issues in renal failure.
Conclusions:
- MPO plays a significant role in CKD pathophysiology.
- MPO-driven oxidative stress and inflammation exacerbate CKD complications.
- Targeting MPO may offer therapeutic potential for cardiovascular disease in CKD.
Abstract:
Chronic kidney disease (CKD) is a worldwide public health problem. Patients with CKD have a number of disorders in the organism, and the presence of oxidative stress and systemic inflammation in these patients is the subject of numerous studies. Chronic inflammation joined with oxidative stress contributes to the development of numerous complications: accelerated atherosclerosis process and cardiovascular disease, emergence of Type 2 diabetes mellitus, development of malnutrition, anaemia, hyperparathyroidism, and so forth, affecting the prognosis and quality of life of patients with CKD. In this review we presented the potential role of the myeloperoxidase enzyme in the production of reactive/chlorinating intermediates and their role in oxidative damage to biomolecules in the body of patients with chronic kidney disease and end-stage renal disease. In addition, we discussed the role of modified lipoprotein particles under the influence of prooxidant MPO intermediates in the development of endothelial changes and cardiovascular complications in renal failure.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Peroxisomes
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

